Ann Hynes
Stock Analyst at Mizuho
(4.61)
# 236
Out of 4,667 analysts
230
Total ratings
67%
Success rate
15.43%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MD Pediatrix Medical Group | Maintains: Neutral | $13 → $15 | $14.49 | +3.52% | 11 | Nov 19, 2024 | |
| ELV Elevance Health | Maintains: Outperform | $585 → $505 | $401.03 | +25.93% | 3 | Nov 5, 2024 | |
| CAH Cardinal Health | Maintains: Neutral | $110 → $120 | $119.77 | +0.19% | 8 | Nov 4, 2024 | |
| BTSG BrightSpring Health Services | Maintains: Outperform | $17 → $20 | $18.79 | +6.44% | 1 | Nov 4, 2024 | |
| DGX Quest Diagnostics | Maintains: Outperform | $160 → $174 | $161.03 | +8.05% | 12 | Oct 24, 2024 | |
| CVS CVS Health | Maintains: Outperform | $73 → $66 | $56.83 | +16.14% | 9 | Oct 24, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Outperform | $28 | $21.26 | +31.70% | 1 | Aug 19, 2024 | |
| ARDT Ardent Health Partners | Initiates: Outperform | $20 | $16.35 | +22.32% | 1 | Aug 12, 2024 | |
| CRL Charles River Laboratories International | Initiates: Neutral | $235 | $187.90 | +25.07% | 1 | Jun 7, 2024 | |
| FTRE Fortrea Holdings | Initiates: Neutral | $27 | $19.15 | +40.99% | 1 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $435 | $326.09 | +33.40% | 1 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $84 → $70 | $39.10 | +79.03% | 9 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $118 → $130 | $149.79 | -13.21% | 14 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $93 → $95 | $98.93 | -3.97% | 8 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $346 | $203.67 | +69.88% | 13 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $370 → $385 | $322.69 | +19.31% | 10 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $200 | $197.52 | +1.26% | 15 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $242 → $268 | $2.18 | +12,193.58% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $450 → $505 | $621.47 | -18.74% | 19 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $550 → $400 | $293.39 | +36.34% | 7 | Jan 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $257 → $230 | $236.79 | -2.87% | 15 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $325 → $275 | $327.00 | -15.90% | 20 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $31 → $25 | $8.24 | +203.40% | 8 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $229 | $194.81 | +17.55% | 10 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $48 → $50 | $22.51 | +122.12% | 2 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $600 → $549 | $599.03 | -8.35% | 16 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $76 | $59.10 | +28.60% | 7 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $345 → $366 | $294.64 | +24.22% | 6 | Jul 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $57 | $1.33 | +4,173.18% | 1 | Sep 21, 2017 |
Pediatrix Medical Group
Nov 19, 2024
Maintains: Neutral
Price Target: $13 → $15
Current: $14.49
Upside: +3.52%
Elevance Health
Nov 5, 2024
Maintains: Outperform
Price Target: $585 → $505
Current: $401.03
Upside: +25.93%
Cardinal Health
Nov 4, 2024
Maintains: Neutral
Price Target: $110 → $120
Current: $119.77
Upside: +0.19%
BrightSpring Health Services
Nov 4, 2024
Maintains: Outperform
Price Target: $17 → $20
Current: $18.79
Upside: +6.44%
Quest Diagnostics
Oct 24, 2024
Maintains: Outperform
Price Target: $160 → $174
Current: $161.03
Upside: +8.05%
CVS Health
Oct 24, 2024
Maintains: Outperform
Price Target: $73 → $66
Current: $56.83
Upside: +16.14%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Outperform
Price Target: $28
Current: $21.26
Upside: +31.70%
Ardent Health Partners
Aug 12, 2024
Initiates: Outperform
Price Target: $20
Current: $16.35
Upside: +22.32%
Charles River Laboratories International
Jun 7, 2024
Initiates: Neutral
Price Target: $235
Current: $187.90
Upside: +25.07%
Fortrea Holdings
May 28, 2024
Initiates: Neutral
Price Target: $27
Current: $19.15
Upside: +40.99%
May 28, 2024
Initiates: Buy
Price Target: $435
Current: $326.09
Upside: +33.40%
May 3, 2024
Maintains: Neutral
Price Target: $84 → $70
Current: $39.10
Upside: +79.03%
May 1, 2024
Reiterates: Buy
Price Target: $118 → $130
Current: $149.79
Upside: -13.21%
Apr 25, 2024
Maintains: Buy
Price Target: $93 → $95
Current: $98.93
Upside: -3.97%
Apr 4, 2024
Reiterates: Buy
Price Target: $346
Current: $203.67
Upside: +69.88%
Mar 8, 2024
Maintains: Buy
Price Target: $370 → $385
Current: $322.69
Upside: +19.31%
Mar 6, 2024
Maintains: Buy
Price Target: $175 → $200
Current: $197.52
Upside: +1.26%
Feb 23, 2024
Maintains: Buy
Price Target: $242 → $268
Current: $2.18
Upside: +12,193.58%
Feb 9, 2024
Maintains: Neutral
Price Target: $450 → $505
Current: $621.47
Upside: -18.74%
Jan 26, 2024
Maintains: Buy
Price Target: $550 → $400
Current: $293.39
Upside: +36.34%
Oct 31, 2023
Maintains: Buy
Price Target: $257 → $230
Current: $236.79
Upside: -2.87%
Oct 25, 2023
Maintains: Buy
Price Target: $325 → $275
Current: $327.00
Upside: -15.90%
Oct 10, 2023
Maintains: Neutral
Price Target: $31 → $25
Current: $8.24
Upside: +203.40%
Oct 10, 2023
Maintains: Buy
Price Target: $250 → $229
Current: $194.81
Upside: +17.55%
Jul 11, 2023
Maintains: Buy
Price Target: $48 → $50
Current: $22.51
Upside: +122.12%
Jul 11, 2023
Maintains: Buy
Price Target: $600 → $549
Current: $599.03
Upside: -8.35%
Jul 11, 2023
Maintains: Neutral
Price Target: $80 → $76
Current: $59.10
Upside: +28.60%
Jul 29, 2022
Maintains: Buy
Price Target: $345 → $366
Current: $294.64
Upside: +24.22%
Sep 21, 2017
Initiates: Neutral
Price Target: $57
Current: $1.33
Upside: +4,173.18%